Risk quantification of early outcome after lung transplantation: Donor, recipient, operative, and post-transplant parameters

被引:49
作者
Sekine, Y [1 ]
Waddell, TK [1 ]
Matte-Martyn, A [1 ]
Pierre, AF [1 ]
de Perrot, M [1 ]
Fischer, S [1 ]
Marshall, J [1 ]
Granton, J [1 ]
Hutcheon, MA [1 ]
Keshavjee, S [1 ]
机构
[1] Univ Toronto, Toronto Gen Hosp, Toronto Lung Transplant Program, Div Thorac Surg,Univ Hlth Network, Toronto, ON M5G 2C4, Canada
关键词
D O I
10.1016/S1053-2498(03)00034-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Because there is no reliable evaluation system of recipient acuity after lung transplantation, comparing patients among centers is difficult. The purpose of our study was to identify risk factors for 30-day mortality and prolonged intensive care unit stay and to develop a scoring system to evaluate the severity of impairment and to predict surgical outcomes. Methods We prospectively collected data from 122 lung transplant recipients and from 119 donors from January 1997 to June 2000. We assessed donor, recipient, and operative factors; ischemic time; and immediate post-operative physiologic parameters to identify risk factors for 30-day mortality and prolonged intensive care unit stay. Furthermore, we sub-classified these factors into grades to develop a scoring system for predicting surgical outcomes. Results Cardiopulmonary bypass use, body mass index > 25 kg/m2, immediate postoperative systolic pulmonary arterial pressure, trend of oxygenation index from 12 to 24 hours after transplantation, and the Acute Physiology and Chronic Health Evaluation 11 score correlated significantly with outcomes, and the sum of these 5 scores correlated strongly with outcomes (P < 0.0001). Conclusions We conclude that the total score of these 5 risk factors could be used to predict 30-day mortality and prolonged intensive care unit stay. This scoring system also will facilitate standardization among transplant centers in evaluating post-transplant severity of illness. J Heart Lung Transplant 2004;23;96-104.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 32 条
[1]   EFFECT OF CARDIOPULMONARY BYPASS ON EARLY GRAFT DYSFUNCTION IN CLINICAL LUNG TRANSPLANTATION [J].
AEBA, R ;
GRIFFITH, BP ;
KORMOS, RL ;
ARMITAGE, JM ;
GASIOR, TA ;
FUHRMAN, CR ;
YOUSEM, SA ;
HARDESTY, RL .
ANNALS OF THORACIC SURGERY, 1994, 57 (03) :715-722
[2]  
Aris R, 1998, AM J RESP CRIT CARE, V158, P335
[3]  
BARIE PS, 1995, ARCH SURG-CHICAGO, V130, P77
[4]  
CERRA FB, 1990, ARCH SURG-CHICAGO, V125, P519
[5]   Primary graft failure following lung transplantation [J].
Christie, JD ;
Bavaria, JE ;
Palevsky, HI ;
Litzky, L ;
Blumenthal, NP ;
Kaiser, LR ;
Kotloff, RM .
CHEST, 1998, 114 (01) :51-60
[6]   Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. [J].
Clark, RH ;
Kueser, TJ ;
Walker, MW ;
Southgate, WM ;
Huckaby, JL ;
Perez, JA ;
Roy, BJ ;
Keszler, M ;
Kinsella, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (07) :469-474
[7]   Inhaled nitric oxide reduces human lung allograft dysfunction [J].
Date, H ;
Triantafillou, AN ;
Trulock, EP ;
Pohl, MS ;
Cooper, JD ;
Patterson, GA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (05) :913-919
[8]   IMPROVED RESULTS OF LUNG TRANSPLANTATION FOR PATIENTS WITH CYSTIC-FIBROSIS [J].
EGAN, TM ;
DETTERBECK, FC ;
MILL, MR ;
PARADOWSKI, LJ ;
LACKNER, RP ;
OGDEN, WD ;
YANKASKAS, JR ;
WESTERMAN, JH ;
THOMPSON, JT ;
WEINER, MA ;
CAIRNS, EL ;
WILCOX, BR .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (02) :224-235
[9]   Low-potassium dextran preservation solution improves lung function after human lung transplantation [J].
Fischer, S ;
Matte-Martyn, A ;
de Perrot, M ;
Waddell, TK ;
Sekine, Y ;
Hutcheon, M ;
Keshavjee, S .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (03) :594-596
[10]   Controlled perfusion decreases reperfusion injury after high-flow reperfusion [J].
Fiser, SM ;
Kron, IL ;
Long, SM ;
Kaza, AK ;
Kern, JA ;
Cassada, DC ;
Laubach, VE ;
Tribble, CG .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (06) :687-691